September 2021

LGC's "incredibly critical" ultra-high-throughput CoVid workflow spotlighted in GenomeWeb

Mark Dearden, Managing Director, Genomics recently caught up with GenomeWeb, to discuss LGC’s "incredibly critical" ultra-high-throughput CoVid workflow.

In addition, the LGC, Biosearch Technologies team, in its latest blog, has looked at the question, “Can COVID-19 testing be made more sustainable during prolonged uncertainty?”

The unpredictable conditions caused by the pandemic need public health control measures and systems to remain flexible, in order to keep up with the virus.

These two blogs outline precisely why LGC’s innovation has allowed us to continue to provide the highest number of PCR tests per day on a single system, at a cost-effective level.